INFERGEN (interferon alfacon-1)

Company
Amgen

Approval Status
Approved October 1997

Treatment for
hepatitis C

Areas
Immune System

A launch has taken place in the U.S. of Amgen's consensus interferon (interferon alfacon-1, INFERGEN) for the treatment of chronic hepatitis C virus infection.

INFERGEN (interferon alfacon-1) Drug Information

The INFERGEN (interferon alfacon-1) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top